164 related articles for article (PubMed ID: 31555127)
1. Study on Metabolic Trajectory of Liver Aging and the Effect of Fufang Zhenzhu Tiaozhi on Aging Mice.
Luo D; Li J; Chen K; Yin Y; Fang Z; Pang H; Rong X; Guo J
Front Pharmacol; 2019; 10():926. PubMed ID: 31555127
[TBL] [Abstract][Full Text] [Related]
2. Untargeted Metabolomics Reveals the Protective Effect of Fufang Zhenshu Tiaozhi (FTZ) on Aging-Induced Osteoporosis in Mice.
Luo D; Li J; Chen K; Rong X; Guo J
Front Pharmacol; 2018; 9():1483. PubMed ID: 30670964
[TBL] [Abstract][Full Text] [Related]
3. Gut microbiota combined with metabolomics reveals the metabolic profile of the normal aging process and the anti-aging effect of FuFang Zhenshu TiaoZhi(FTZ) in mice.
Luo D; Chen K; Li J; Fang Z; Pang H; Yin Y; Rong X; Guo J
Biomed Pharmacother; 2020 Jan; 121():109550. PubMed ID: 31704617
[TBL] [Abstract][Full Text] [Related]
4. An integrated fecal microbiome and metabolome in the aged mice reveal anti-aging effects from the intestines and biochemical mechanism of FuFang zhenshu TiaoZhi(FTZ).
Shenghua P; Ziqin Z; Shuyu T; Huixia Z; Xianglu R; Jiao G
Biomed Pharmacother; 2020 Jan; 121():109421. PubMed ID: 31743877
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanism of Fufang Zhenzhu Tiaozhi capsule in the treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease based on network pharmacology and validation in minipigs.
Wang H; Tan H; Zhan W; Song L; Zhang D; Chen X; Lin Z; Wang W; Yang Y; Wang L; Bei W; Guo J
J Ethnopharmacol; 2021 Jun; 274():114056. PubMed ID: 33771638
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the Constituents in Rat Serum after Oral Administration of Fufang Zhenzhu Tiaozhi Capsule by UPLC-Q-TOF-MS/MS.
Zhong X; Guo J; Wang L; Luo D; Bei W; Chen Y; Yan K; Peng J
Chromatographia; 2012 Feb; 75(3-4):111-129. PubMed ID: 22307991
[TBL] [Abstract][Full Text] [Related]
7. The traditional Chinese medicine formula Fufang-Zhenzhu-Tiaozhi protects myocardia from injury in diabetic minipigs with coronary heart disease.
Song L; Zhang D; Guo C; Gu Z; Wang L; Yao YS; Wang H; Zeng Z; Wang W; Yang Y; Bei W; Rong X; Guo J
Biomed Pharmacother; 2021 May; 137():111343. PubMed ID: 33761594
[TBL] [Abstract][Full Text] [Related]
8. Metabolomics study of the hepatoprotective effect of Phellinus igniarius in chronic ethanol-induced liver injury mice using UPLC-Q/TOF-MS combined with ingenuity pathway analysis.
Dong Y; Qiu P; Zhao L; Zhang P; Huang X; Li C; Chai K; Shou D
Phytomedicine; 2020 Aug; 74():152697. PubMed ID: 30392748
[TBL] [Abstract][Full Text] [Related]
9. Chemical Fingerprint Analysis and Ultra-Performance Liquid Chromatography Quadrupole Time-of-Flight Mass Spectrometry-Based Metabolomics Study of the Protective Effect of Buxue Yimu Granule in Medical-Induced Incomplete Abortion Rats.
Zhang Y; Li W; Chen TT; Yang Y; Wu MY; Luo JY; Gong Y; Zou L
Front Pharmacol; 2020; 11():578217. PubMed ID: 33328985
[TBL] [Abstract][Full Text] [Related]
10. The Chinese medicine Fufang Zhenzhu Tiaozhi capsule protects against renal injury and inflammation in mice with diabetic kidney disease.
Yang YQ; Tan HB; Zhang XY; Zhang YZ; Lin QY; Huang MY; Lin ZY; Mo JZ; Zhang Y; Lan T; Bei WJ; Guo J
J Ethnopharmacol; 2022 Jun; 292():115165. PubMed ID: 35247475
[TBL] [Abstract][Full Text] [Related]
11. [Metabolomic study on urine of chronic inflammation rats treated with Buyang Huanwu Decoction based on UPLC-Q-TOF-MS].
You XY; Jiang L; Wang WF; Xu X; Zhang SW; Liu HN; Yan XJ; Nie P; Li BT; Xu GL
Zhongguo Zhong Yao Za Zhi; 2023 Oct; 48(19):5345-5355. PubMed ID: 38114124
[TBL] [Abstract][Full Text] [Related]
12. [Metabolomics study of Danggui Buxue Tang on treatment of type 2 diabetes mice using UHPLC-Q-TOF-MS].
Sun LL; Bai HY; Zheng WH; Wang LY; Zhao W; Li JY; Shi YB; Yang ZG
Zhongguo Zhong Yao Za Zhi; 2020 Feb; 45(3):636-644. PubMed ID: 32237524
[TBL] [Abstract][Full Text] [Related]
13. Fufang-zhenzhu-tiaozhi formula protects islet against injury and promotes β cell regeneration in diabetic mice.
Chen X; Yin J; Zhong Q; Wang K; Zhang X; Liang M; Lin Q; Wang H; Wang W; Wang L; Hu X; Bei W; Guo J
J Ethnopharmacol; 2023 Jan; 301():115791. PubMed ID: 36240976
[TBL] [Abstract][Full Text] [Related]
14. Fufang Zhenzhu Tiaozhi Capsule Prevents Intestinal Inflammation and Barrier Disruption in Mice With Non-Alcoholic Steatohepatitis.
Lan T; Xu T; Fu Y; Jiang S; Liang X; Yu Z; Pan L; Rong X; Guo J
Front Endocrinol (Lausanne); 2022; 13():864703. PubMed ID: 35784533
[TBL] [Abstract][Full Text] [Related]
15. The Chinese medicine Fufang Zhenzhu Tiaozhi capsule protects against atherosclerosis by suppressing EndMT via modulating Akt1/β-catenin signaling pathway.
Diao H; Cheng J; Huang X; Huang B; Shao X; Zhao J; Lan D; Zhu Q; Yan M; Zhang Y; Rong X; Guo J
J Ethnopharmacol; 2022 Jul; 293():115261. PubMed ID: 35447198
[TBL] [Abstract][Full Text] [Related]
16. The Chinese herbal medicine Fufang Zhenzhu Tiaozhi ameliorates diabetic cardiomyopathy by regulating cardiac abnormal lipid metabolism and mitochondrial dynamics in diabetic mice.
Yan M; Liu S; Zeng W; Guo Q; Mei Y; Shao X; Su L; Liu Z; Zhang Y; Wang L; Diao H; Rong X; Guo J
Biomed Pharmacother; 2023 Aug; 164():114919. PubMed ID: 37302318
[TBL] [Abstract][Full Text] [Related]
17. Fufang Zhenzhu Tiaozhi (FTZ) capsule ameliorates diabetes-accelerated atherosclerosis via suppressing YTHDF2-mediated m
Zhang Y; Wang R; Tan H; Wu K; Hu Y; Diao H; Wang D; Tang X; Leng M; Li X; Cai Z; Luo D; Shao X; Yan M; Chen Y; Rong X; Guo J
J Ethnopharmacol; 2023 Dec; 317():116766. PubMed ID: 37343655
[TBL] [Abstract][Full Text] [Related]
18. Metabolomics study on liver of db/db mice treated with curcumin using UPLC-Q-TOF-MS.
Jiang Y; Qu K; Liu J; Wen Y; Duan B
J Pharm Biomed Anal; 2022 Jun; 215():114771. PubMed ID: 35461164
[TBL] [Abstract][Full Text] [Related]
19. Fufang-Zhenzhu-Tiaozhi Capsule reduces restenosis via the downregulation of NF-kappaB and inflammatory factors in rabbits.
Zhang R; Li T; Guo J; Zhao Y; Liu Y; Yao Y; Zeng Z
Lipids Health Dis; 2018 Nov; 17(1):272. PubMed ID: 30497486
[TBL] [Abstract][Full Text] [Related]
20. An unbiased lipidomics approach identifies key lipid molecules as potential therapeutic targets of Dohongsamul-tang against non-alcoholic fatty liver diseases in a mouse model of obesity.
Park SH; Lee JE; Lee SM; Lee J; Seo CS; Hwang GS; Jung J
J Ethnopharmacol; 2020 Oct; 260():112999. PubMed ID: 32454173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
